SENZER
Dead / Cancelled — Cancelled — Section 8 (as of 21 Jun 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86745982
- Registration number
- 5348473
- Mark type
- Stylized text
- Filed
- 02 Sept 2015
- Published for opposition
- 19 Sept 2017
- Registered
- 05 Dec 2017
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal, and cardiovascular disorders; substances adapted for medical use, namely, cannabinoids for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, other intestinal, neurological and cardiovascular disorders; vaccines for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and intestinal and cardiovascular disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the form of powders, capsules, inhalers, that facilitate the delivery of pharmaceutical preparations; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases
- Class 010 — Medical apparatus: Inhalers for medical purposes; filters for inhalers for medical purposes; inhalers for medical use; inhalers for therapeutic use; drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; microneedle arrays for delivering medications; hypodermic syringes for injections for medical purposes; all of the aforesaid for use in delivering pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and intestinal, neurological and cardiovascular disorders; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases
Owner
- SENZER LIMITED, LONDON, GB
- Kinhold IP Limited, London, GB
- Kinhold IP Limited, London, GB
- Kinhold IP Limited, London, GB
Prosecution history
- 21 Jun 2024 — CANCELLED SEC. 8 (6-YR)
- 14 Sept 2023 — WITHDRAWAL OF ATTORNEY GRANTED
- 14 Sept 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 05 Dec 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Aug 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Dec 2017 — REGISTERED-PRINCIPAL REGISTER
- 19 Sept 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Sept 2017 — PUBLISHED FOR OPPOSITION
- 30 Aug 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2017 — ELECTRONIC RECORD REVIEW COMPLETE
- 11 Aug 2017 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 07 Aug 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Jul 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jul 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jul 2017 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED